Table 4.
Adverse Events (n = 52) | Number of Adverse Effects (%) | Prevalence of Adverse Effects in the Study Population (n = 83) (%) |
---|---|---|
Weight gain | 21 (30.1) | 25.3 |
Abnormal uterine bleeding * | 14 (26.9) | 16.9 |
Headache | 11 (21.2) | 13.3 |
Depression | 5 (9.6) | 6.0 |
Decrease libido | 2 (3.8) | 2.4 |
Acne | 1 (1.9) | 1.2 |
* Consisting in irregular bleeding cycle or intermenstrual spotting/bleeding.